Cogent Biosciences, Inc. SEC filings COGT
Cogent Biosciences, Inc. has 616 filings in SEC EDGAR's recent list, going back to Oct 20, 2014. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Aug 10, 2026 | — |
| S-8 | Employee stock plan registration | Feb 17, 2026 | — |
| 424B5 | Prospectus supplement | Nov 12, 2025 | — |
| 424B5 | Prospectus supplement | Nov 12, 2025 | — |
| FWP | Free writing prospectus | Nov 12, 2025 | — |
| 424B5 | Prospectus supplement | Nov 12, 2025 | — |
| 424B5 | Prospectus supplement | Nov 12, 2025 | — |
| S-3ASR | Automatic shelf registration | Nov 7, 2025 | — |
| 424B5 | Prospectus supplement | Jul 9, 2025 | — |
| 424B5 | Prospectus supplement | Jul 8, 2025 | — |
| 424B5 | Prospectus supplement | May 6, 2025 | — |
| POS AM | Filing | May 6, 2025 | — |
| S-8 | Employee stock plan registration | Feb 25, 2025 | — |
| S-8 | Employee stock plan registration | Aug 6, 2024 | — |
| S-3 | Shelf registration | Mar 29, 2024 | — |
| S-8 | Employee stock plan registration | Feb 26, 2024 | — |
| S-8 | Employee stock plan registration | Aug 8, 2023 | — |
| 424B5 | Prospectus supplement | Jun 8, 2023 | — |
| 424B5 | Prospectus supplement | Jun 6, 2023 | — |
| S-8 | Employee stock plan registration | Mar 14, 2023 | — |
| S-3ASR | Automatic shelf registration | Feb 10, 2023 | — |
| 424B5 | Prospectus supplement | Jun 15, 2022 | — |
| FWP | Free writing prospectus | Jun 14, 2022 | — |
| 424B5 | Prospectus supplement | Jun 13, 2022 | — |
| S-3 | Shelf registration | May 6, 2022 | — |
| POS AM | Filing | May 6, 2022 | — |
| S-8 | Employee stock plan registration | Mar 17, 2022 | — |
| S-8 | Employee stock plan registration | Aug 17, 2021 | — |
| S-8 | Employee stock plan registration | Mar 16, 2021 | — |
| S-3 | Shelf registration | Feb 9, 2021 | — |
| 424B5 | Prospectus supplement | Dec 2, 2020 | — |
| 424B3 | Prospectus | Dec 2, 2020 | — |
| 424B5 | Prospectus supplement | Nov 30, 2020 | — |
| S-8 | Employee stock plan registration | Nov 5, 2020 | — |
| S-3 | Shelf registration | Sep 22, 2020 | — |
| S-8 | Employee stock plan registration | Mar 26, 2020 | — |
| 424B5 | Prospectus supplement | Mar 20, 2020 | — |
| S-3 | Shelf registration | Apr 2, 2019 | — |
| S-8 | Employee stock plan registration | Mar 28, 2019 | — |
| S-8 | Employee stock plan registration | Apr 4, 2018 | — |
| 424B4 | Prospectus | Mar 29, 2018 | — |
| FWP | Free writing prospectus | Mar 27, 2018 | — |
| S-1/A | Amended registration statement | Mar 19, 2018 | — |
| S-1 | Registration statement | Mar 2, 2018 | — |
Showing 44 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- COGT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Waltham, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1622229
- Former names
- Unum Therapeutics Inc. (until Oct 5, 2020); Unum Therapeutics, Inc. (until Mar 30, 2018)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.